Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0851184 (
thinning
)
11,252
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with unknown etiology. Recent genetic studies have identified
RNF213
as an important susceptibility gene for MMD. To evaluate the role of
RNF213
in vascular remodeling,
RNF213
knockout mice (
RNF213
-/-) and their wild-type littermates (WT) were subjected to common carotid artery ligation to induce vascular hyperplasia. We examined the vascular expression of matrix metalloproteinase (MMP)-9, known to be increased in MMD. MMP-9 expression was significantly higher in
RNF213
-/- mice than in wild-type mice 1 and 7 days after common carotid artery ligation. The vascular wall was significantly thinner in
RNF213
-/- mice at 14 days. The increased vascular expression of MMP-9 and subsequent vascular wall
thinning
in
RNF213
-/- mice could reflect the early characteristic of MMD, consistent with the recently proposed constrictive remodeling theory.
...
PMID:Increased vascular MMP-9 in mice lacking RNF213: moyamoya disease susceptibility gene. 2538 61